Ukraine War Puts The Pharmaceutical Industry To The Test
Pharmaceutical leaders are responding to the many and varied challenges arising from the war in Ukraine.
You may also be interested in...
Medicines for Europe has urged the European Commission to exempt pharmaceutical suppliers, particularly those of biologic and antibiotic medicines, from any perspective energy rationing in the region, in line with new public guidelines.
Medicines for Europe has called for alterations to regulations concerning the off-patent drug sector, which it says will allow the industry to respond more effectively to the region’s dramatic rise in inflation.